ArticleCase reports in oncology
Ewing Sarcoma in a Patient with a Multisystem Phenotype: Navigating the Intersection of a Potential Novel Syndrome, Scleroderma, and Paraneoplastic Mechanisms ‑ A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ewing sarcoma is a rare, aggressive bone and soft tissue tumor. Its occurrence in a patient with a complex, multisystem congenital history suggests an underlying genetic predisposition and presents significant diagnostic and therapeutic challenges. Associations between sarcomas and scleroderma-like changes, though rare, are documented as paraneoplastic phenomena. Case Presentation: A 26-year-old Arab male with a longstanding history of congenital hearing loss, growth failure, hypothyroidism, and localized scleroderma presented with a popliteal mass. Despite initial management for a scleroderma flare, a biopsy confirmed Ewing sarcoma with bone metastases (stage IVb). Given his complex phenotype and potential underlying DNA repair disorder, a multidisciplinary team initiated a modified chemotherapy regimen (alternating VDC/IE). The initial response was favorable, with tumor necrosis and shrinkage and no significant toxicity. Conclusion: This report underscores the complex interplay between connective tissue disease, genetic susceptibility, and oncogenesis. It emphasizes the importance of a high index of suspicion for paraneoplastic syndromes or underlying genetic disorders in atypical cancer presentations and advocates for a multidisciplinary, personalized treatment approach to balance efficacy with potential toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.